Since PDXs are directly established from patients and thus closely reproduce the genetic, molecular and histological heterogeneity of original tumor, in the present study, we generated capmatinib resistant PDXs and show that TWIST1 was significantly expressed at the time of MET TKI as well as in a separate EGFR TKI resistance PDX model (Fig. 1). Here, TWIST1 is linked to neoplasm.